DRIO · DarioHealth Corp. · Exempt Offerings
$2.38
-0.35 (-12.84%)
At close · Nov 6
Return incl. dividend (before tax)
Q1 2026 earnings call transcript
Going-concern doubt
— cleared Aug 11, 2026
The latest filing no longer states the doubt (first flagged May 13, 2026).
View the 10-Q filed Aug 11, 2026Market Cap
$23.27M
Shares
9.80M
Volume · Nov 6
14.9K
Avg daily vol (3M)
38.18K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2025-10-07 | New | Other Technology | $17,500,000 | $17,500,000 | 06b |
| 2025-01-17 | New | Other Technology | $18,805,000 | $18,805,000 | 06b |
| 2025-01-17 | New | Other Technology | $6,800,000 | $6,800,000 | 06b |
| 2024-02-29 | New | Other Technology | $22,422,000 | $22,422,000 | 06b |
| 2023-05-16 | New | Other Technology | $15,400,000 | $15,400,000 | 06b |
| 2021-06-17 | New | Biotechnology | $24,000,000 | $24,000,000 | 06b |
| 2021-02-17 | New | Biotechnology | $31,000,000 | $31,000,000 | 06b |
| 2021-02-03 | New | Biotechnology | $70,000,000 | $70,000,000 | 06b |
| 2020-08-04 | New | Biotechnology | $30,000,000 | $28,590,801 | 06b |
Showing 1–9 of 9 filings
Key facts
CIK
1533998
CUSIP
23725P308
13F (30d)
12 filings
6 filers
Visit website
Investor relations